Kevin R Thornal Hologic Inc (HOLX) insider trading activity

Kevin R Thornal is Group Pres, Global Diagnostics of HOLOGIC INC. Currently has a direct ownership of 62,368 shares of HOLX, which is worth approximately $5.13 Million. The most recent transaction as insider was on Nov 15, 2022, when has been sold 19,118 shares (Common Stock) at a price of $75.34 per share, resulting in proceeds of $1,440,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.4K

0% 3M change

0% 12M change

Total Value Held $5.13 Million

Kevin R Thornal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2022	SELL Open market or private sale	$1,440,350 $75.34 p/Share	19,118 Reduced 23.46%	62,368 Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	$510,216 $40.85 p/Share	12,490 Added 14.3%	74,858 Common Stock
Nov 11 2022	SELL Payment of exercise price or tax liability	$666,665 $75.93 p/Share	8,780 Reduced 11.29%	68,996 Common Stock
Nov 09 2022	SELL Payment of exercise price or tax liability	$42,617 $72.11 p/Share	591 Reduced 0.75%	77,776 Common Stock
Nov 08 2022	SELL Payment of exercise price or tax liability	$52,260 $73.71 p/Share	709 Reduced 0.9%	78,367 Common Stock
Nov 07 2022	BUY Grant, award, or other acquisition	-	6,724 Added 7.84%	79,076 Common Stock
Nov 01 2022	BUY Grant, award, or other acquisition	-	12,277 Added 14.51%	72,352 Common Stock
Nov 12 2021	SELL Payment of exercise price or tax liability	$502,499 $73.54 p/Share	6,833 Reduced 10.21%	60,075 Common Stock
Nov 11 2021	SELL Payment of exercise price or tax liability	$45,890 $72.61 p/Share	632 Reduced 0.94%	66,908 Common Stock
Nov 09 2021	SELL Payment of exercise price or tax liability	$42,043 $71.26 p/Share	590 Reduced 0.87%	67,540 Common Stock
Nov 08 2021	BUY Grant, award, or other acquisition	-	6,150 Added 8.28%	68,130 Common Stock
Nov 01 2021	BUY Grant, award, or other acquisition	-	28,764 Added 31.7%	61,980 Common Stock
Dec 10 2020	SELL Open market or private sale	$1,248,137 $73.99 p/Share	16,869 Reduced 33.68%	33,216 Common Stock
Dec 10 2020	BUY Exercise of conversion of derivative security	$654,517 $38.8 p/Share	16,869 Added 28.44%	42,452 Common Stock
Dec 01 2020	SELL Payment of exercise price or tax liability	$379,483 $69.63 p/Share	5,450 Reduced 14.1%	33,216 Common Stock
Nov 12 2020	SELL Payment of exercise price or tax liability	$41,980 $70.2 p/Share	598 Reduced 1.52%	38,666 Common Stock
Nov 11 2020	SELL Payment of exercise price or tax liability	$44,139 $69.84 p/Share	632 Reduced 1.58%	39,264 Common Stock
Nov 09 2020	BUY Grant, award, or other acquisition	-	5,120 Added 11.37%	39,896 Common Stock
Nov 02 2020	BUY Grant, award, or other acquisition	-	17,750 Added 33.79%	34,776 Common Stock

Also insider at

NVRO

NEVRO CORP Healthcare

President & CEO

KRT

Kevin R Thornal

Group Pres, Global Diagnostics

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HOLX shares.

Notify only if

Value

Insider Trading

Get notified when an Hologic Inc insider buys or sells HOLX shares.

Notify only if

Operation

Value

Type

News

Receive news related to HOLOGIC INC

Track Activities on HOLX

Account